Frontlight ResearchEarly access
Trial site
IRCCS Azienda Ospedaliera-Universitaria di Bologna
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Idiopathic pulmonary fibrosis2 trials
- Neuroendocrine tumours2 trials
- Pancreatic cancer2 trials
- Liver and biliary tract cancer1 trial
- Liver cirrhosis1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Phase
- Phase 21 trial
- Phase 31 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed2 trials
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna5 trials
- Azienda Ospedaliera di Padova1 trial
- Crinetics Pharmaceuticals Inc.1 trial
- Italian Association Neuroendocrine Tumors1 trial
Running trials
Active, not recruiting
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Recruiting
Recruiting
Efficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+
Active, not recruiting
Recruiting
Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Neuroendocrine tumours1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026